FIAPro™ Thyroid Marker Detection Platform

An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

CE-marked fluorescence immunoassay (FIA) analyzer for quantitative point-of-care testing. The MF-T1000 platform delivers rapid diagnostic results with 92.9%+ sensitivity, supporting respiratory combo tests (4-in-1/9-in-1 configurations) for clinical laboratories and healthcare facilities.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

Proprietary microarray technology platform for immunological testing and allergen detection. Enables high-throughput analysis of biological markers in clinical diagnostics.

A next-generation diagnostic platform using high-frequency SH-SAW sensor technology to detect biomarkers for heart disease, inflammation, and cancer. The platform processes 5 μL of whole blood without red blood cell interference and delivers results in under 3 minutes.

Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.

A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.

Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.

Integrated platform for advanced biomarker analysis supporting early disease detection, risk stratification, and prognostic assessment across cardiometabolic, liver, cardiovascular, and brain health conditions.